MeSH Review:
Muscle Spasticity
- Cannabinoids in multiple sclerosis: do they have a therapeutic role? Killestein, J., Uitdehaag, B.M., Polman, C.H. Drugs (2004)
- Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Ward, A., Chaffman, M.O., Sorkin, E.M. Drugs (1986)
- Levodopa-enhanced recovery from paralysis induced by air embolism. Popovic, P., Popovic, V., Schaffer, R. Surgery (1976)
- A focused review of the use of botulinum toxins for low back pain. Difazio, M., Jabbari, B. The Clinical journal of pain. (2002)
- Neurological manifestations of baclofen withdrawal. Rivas, D.A., Chancellor, M.B., Hill, K., Freedman, M.K. J. Urol. (1993)
- Quantitative features of the stretch response of extrinsic finger muscles in hemiparetic stroke. Kamper, D.G., Rymer, W.Z. Muscle Nerve (2000)
- Anaerobic threshold in wheelchair athletes with cerebral palsy: validity and reliability. Bhambhani, Y.N., Holland, L.J., Steadward, R.D. Archives of physical medicine and rehabilitation. (1993)
- Cost-effectiveness comparison of tizanidine and baclofen in the management of spasticity. Rushton, D.N., Lloyd, A.C., Anderson, P.M. PharmacoEconomics. (2002)
- Prolonged severe withdrawal symptoms after acute-on-chronic baclofen overdose. Peng, C.T., Ger, J., Yang, C.C., Tsai, W.J., Deng, J.F., Bullard, M.J. J. Toxicol. Clin. Toxicol. (1998)
- Dantrolene sodium: long-term effects in patients with muscle spasticity. Joynt, R.L. Archives of physical medicine and rehabilitation. (1976)